Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM)
CUSIP: 00534B100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,195,785
- Total 13F shares
- 11,593,031
- Share change
- +791,234
- Total reported value
- $9,331,190
- Price per share
- $0.80
- Number of holders
- 14
- Value change
- +$632,839
- Number of buys
- 6
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 00534B100?
CUSIP 00534B100 identifies ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00534B100:
Top shareholders of ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
44%
|
9,812,419
|
$10,303,039 | — | 31 Dec 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.96%
|
213,235
|
$223,897 | — | 31 Dec 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.94%
|
209,361
|
$219,829 | — | 31 Dec 2024 | |
| Shaolin Capital Management LLC |
13F
|
Company |
0.89%
|
197,500
|
$207,374 | — | 31 Dec 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.5%
|
110,571
|
$116,100 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.45%
|
100,000
|
$105,000 | — | 31 Dec 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.35%
|
76,757
|
$80,595 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
22,752
|
$23,888 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.1%
|
21,180
|
$22,239 | — | 31 Dec 2024 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0.09%
|
20,000
|
$21,000 | — | 31 Dec 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
12,120
|
$13,000 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
4,454
|
$4,676 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,409
|
$1,479 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
29
|
$30 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
10
|
$11 | — | 31 Dec 2024 | |
| James L. Cox |
3/4/5
|
Director |
—
mixed-class rows
|
400,698
mixed-class rows
|
— | — | 20 Mar 2025 | |
| Orly Mishan |
3/4/5
|
Director |
—
class O/S missing
|
300,000
|
— | — | 20 Mar 2025 | |
| Olav Bergheim |
3/4/5
|
CEO, Director |
—
class O/S missing
|
234,134
|
— | — | 31 Jul 2024 | |
| Keyvan Mirsaeedi-Farahani |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 20 Mar 2025 | |
| Sandra A. Gardiner |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 20 Mar 2025 | |
| Timothy P. Moran |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 20 Mar 2025 | |
| Hakon Bergheim |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
8,539
mixed-class rows
|
— | — | 31 Jul 2024 |
Institutional Holders of Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) as of Q1 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.